KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovoCure (NVCR) Gross Profit (2016 - 2025)

Historic Gross Profit for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $122.5 million.

  • NovoCure's Gross Profit rose 229.86% to $122.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $484.1 million, marking a year-over-year increase of 965.28%. This contributed to the annual value of $468.0 million for FY2024, which is 2282.62% up from last year.
  • Latest data reveals that NovoCure reported Gross Profit of $122.5 million as of Q3 2025, which was up 229.86% from $117.3 million recorded in Q2 2025.
  • In the past 5 years, NovoCure's Gross Profit ranged from a high of $127.8 million in Q4 2024 and a low of $92.0 million during Q2 2023
  • Moreover, its 5-year median value for Gross Profit was $104.9 million (2021), whereas its average is $107.8 million.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 4005.84% in 2021, then tumbled by 1809.31% in 2023.
  • NovoCure's Gross Profit (Quarter) stood at $103.5 million in 2021, then fell by 3.85% to $99.5 million in 2022, then increased by 1.69% to $101.2 million in 2023, then rose by 26.25% to $127.8 million in 2024, then decreased by 4.17% to $122.5 million in 2025.
  • Its Gross Profit was $122.5 million in Q3 2025, compared to $117.3 million in Q2 2025 and $116.5 million in Q1 2025.